The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Substudy G of the Canadian cancer trials group (CCTG) IND.234: PC_BETS (V)—A circulating tumor DNA (ctDNA)–directed phase II study of carboplatin in patients (Pts) with previously treated metastatic castration-resistant prostate cancer (mCRPC).
 
April Rose
Employment - Merck (I)
Stock and Other Ownership Interests - Merck (I)
Consulting or Advisory Role - Advanced Accelerator Applications/Novartis; EMD Serono; Pfizer
Research Funding - AstraZeneca Canada; AstraZeneca Canada (Inst); Canada Foundation for Innovation; Canadian Cancer Society; Canadian Institutes of Health Research (CIHR); Conquer Cancer Foundation; Jewish General Hospital Foundation; Merck (Inst); Pfizer; Pfizer (Inst); Seagen (Inst); TransMedTech Institute
Travel, Accommodations, Expenses - Pfizer
 
Sebastien Hotte
Honoraria - Advanced Accelerator Applications/Novartis; Astellas Scientific and Medical Affairs Inc; Bayer
Consulting or Advisory Role - Astellas Pharma; Bayer; Janssen; Merck; Novartis Canada Pharmaceuticals Inc; Pfizer
Research Funding - Astellas Pharma (Inst); AstraZeneca (Inst); Ayala Pharmaceuticals (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); ESSA (Inst); Janssen Oncology (Inst); Merck (Inst); Pfizer (Inst); Seagen (Inst); SignalChem (Inst)
 
Eric Winquist
Consulting or Advisory Role - Bayer; Eisai; EMD Serono; Ipsen; Merck; Roche
Research Funding - Lilly (Inst); Merck (Inst); Novartis (Inst)
 
Robyn Macfarlane
Honoraria - IPSEN
Consulting or Advisory Role - Bayer; Bristol-Myers Squibb; Genzyme; Janssen; Merck; Novartis Canada Pharmaceuticals Inc
 
Kim Chi
Honoraria - Amgen; Astellas Pharma; AstraZeneca; Bayer; BMS GmbH & Co. KG; BMS GmbH & Co. KG; Janssen; Merck; Novartis; Pfizer; POINT Biopharma; Roche
Consulting or Advisory Role - Amgen; Astellas Pharma; AstraZeneca; Bayer; BMS GmbH & Co. KG; Janssen; Merck; POINT Biopharma; Roche
Research Funding - Astellas Pharma (Inst); AstraZeneca (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); ESSA (Inst); Janssen (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst); Roche (Inst); Sanofi (Inst)
 
Michael Kolinsky
Honoraria - AstraZeneca; Bayer; Eisai; EMD Serono; Janssen; Merck; Pfizer
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb; Eisai; EMD Serono; Ipsen; Janssen; Merck
Research Funding - Janssen (Inst)
 
Muhammad Salim
No Relationships to Disclose
 
Di Maria Jiang
Honoraria - Amgen; Astellas Pharma; Astellas Pharma; Astellas Pharma; AstraZeneca; Bayer; Bayer; Bayer; Bayer; EMD Serono; Ipsen; Janssen Oncology; Janssen Oncology; Janssen Oncology; Janssen Oncology; Medunik; Novartis AAA
Consulting or Advisory Role - AstraZeneca/Merck; Bayer; Janssen Oncology; McKesson; Merck; Novartis AAA; Pfizer; Pfizer/EMD Serono; Pfizer/EMD Serono; Pfizer/EMD Serono; Seagen
Research Funding - Amgen; Astellas Pharma (Inst); Bayer; Pfizer; Tersera
Travel, Accommodations, Expenses - Amgen; AstraZeneca; Bayer; EMD Serono; EMD Serono; Pfizer; Pfizer; Pfizer; Pfizer; Roche
 
Michael Ong
Honoraria - AstraZeneca; Bayer; Bristol-Myers Squibb; EMD Serono; Janssen; Merck; Novartis / AAA; Pfizer
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Janssen; Merck; Pfizer/EMD Serono; Sanofi
Research Funding - AstraZeneca (Inst); BMS (Inst)
Travel, Accommodations, Expenses - Ipsen; Janssen
 
Cristiano Ferrario
Honoraria - AstraZeneca; Bayer; Janssen Oncology; Merck; Novartis; Pfizer; Roche Canada; Seagen
Consulting or Advisory Role - AstraZeneca; Gilead Sciences; Merck; Novartis; Roche
Research Funding - Astellas Pharma (Inst); AstraZeneca (Inst); Janssen Oncology (Inst); Lilly (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst); Roche/Genentech (Inst); Seagen (Inst)
Travel, Accommodations, Expenses - Johnson & Johnson/Janssen
 
Aly-Khan Lalani
Honoraria - Astellas Pharma; Bayer; Bristol-Myers Squibb; Eisai; Ipsen; Merck; Novartis; Pfizer; Roche/Genentech
Consulting or Advisory Role - Abbvie; Astellas Pharma; Bayer; Bristol-Myers Squibb; Eisai; Ipsen; Janssen; Merck; Novartis; Pfizer
Research Funding - BioCanRx (Inst); Bristol-Myers Squibb (Inst); EMD Serono (Inst); Ipsen (Inst); Novartis (Inst); Roche (Inst)
 
D. Ernst
Consulting or Advisory Role - Bristol-Myers Squibb; Merck; Novartis Canada Pharmaceuticals Inc; Pfizer; Sanofi
Research Funding - Pfizer
 
Parvaneh Fallah
Honoraria - AstraZeneca; Seagen
Travel, Accommodations, Expenses - EMD Serono/Merck
 
Matti Annala
Leadership - Fluivia
Stock and Other Ownership Interests - Fluivia
 
Edmond Kwan
No Relationships to Disclose
 
Francisco Vera Badillo
Consulting or Advisory Role - AstraZeneca; AstraZeneca; Bayer; Bayer; Janssen Oncology; Janssen Oncology; Janssen Oncology; Merck; Merck; Merck Serono
Research Funding - AstraZeneca/MedImmune (Inst); Janssen Oncology (Inst)
Travel, Accommodations, Expenses - Janssen Oncology; Janssen Oncology; Janssen Oncology
 
Lesley Seymour
Stock and Other Ownership Interests - AstraZeneca
Research Funding - AstraZeneca (Inst); Bayer (Inst); GlaxoSmithKline (Inst); Janssen Oncology (Inst); Merck (Inst); Novartis (Inst); Repare Therapeutics (Inst)
 
Wei Tu
No Relationships to Disclose
 
Alexander Wyatt
Honoraria - AstraZeneca; Bayer; Janssen; Merck; Pfizer
Research Funding - ESSA (Inst); Promontory Therapeutics (Inst); Tyra Biosciences (Inst)
 
Mariam Jafri
No Relationships to Disclose